Clinical Trial Update: Safety and Efficacy of Glucosanol in Reducing Body Weight in Overweight and Obese Subjects [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the safety and effectiveness of Glucosanol for reducing body weight in overweight and obese adults. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Glucosanol

Snippet

Sponsor: InQpharm Group | Conditions: Overweight and Obesity | Phase 4 | Status: COMPLETED